FDA to Remove Black Box Warnings on Menopause Hormone Therapy
TL;DR
The FDA has decided to remove the black box warning on hormone replacement therapy for menopause, citing new evidence of its benefits and nuanced risks, which could lead to increased use among women experiencing menopause symptoms.
- FDA reverses decades of guidance on hormone therapy for menopause NPR
- F.D.A. Will Remove Black Box Warnings From Hormone Treatments for Menopause The New York Times
- FDA removes warning labels from hormone therapy products for menopause NPR
- HHS Secretary Kennedy News Conference on Hormone Replacement Therapy C-SPAN
- WATCH: RFK Jr. says FDA will remove long-standing warning from hormone-based menopause drugs PBS
Want the full story? Read the original reporting
Read on NPR